公司资料
Bellerophon Therapeutics 股价、新闻与催化剂
- 股票代码:
- BLPH
- 交易所:
- PINK
- 行业:
- Biopharma
- 所在地:
- United States
股价为何变动
Current closing-price context is not available for BLPH.
公司概览
业务概览
Bellerophon Therapeutics was a pulmonary-hypertension company focused on inhaled nitric-oxide and cardiopulmonary science before its restructuring and public-market decline. Its platform targeted severe lung disease.
所在地与行业分类
Headquartered in the United States and listed on NASDAQ before restructuring, Bellerophon sat in specialty biotechnology.
商业模式特征
The business depended on clinical validation, delivery science, and the ability to commercialize a focused respiratory platform.
生物医药行业定位
Bellerophon belongs to the historical respiratory-biotech set rather than the current live public-company set.
未来催化剂
- Bellerophon Therapeutics’s catalysts are INOpulse-related updates and any strategic move that clarifies the company’s future. The market is mostly waiting to see whether there is still a viable commercial or asset path.
近期新闻
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。